"Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 worldwide due to the patent expiry of several leading drugs, according to research and consulting firm GlobalData."

"According to the analyst's report, the drug makers hit hardest will include Otsuka, Eli Lilly, and AstraZeneca (AZ), with a significant proportion of losses coming in the Central Nervous System (CNS) treatment sector."

From BioSpectrum Asia: http://ow.ly/FNwgM´╗┐

Pharma sector may lose $65 bn by 2019: Analyst
According to research and consulting firm GlobalData, the loss is due to the patent expiry of several leading drugs

Tags:

Comments are closed.